Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Hospitals don’t want to do trials anymore..
View:
Post by hmmmmmmmm on Feb 22, 2023 7:29pm

Hospitals don’t want to do trials anymore..

That’s the latest excuse being told- from and insider at the company.
 
Saying the reason they can only add 1 patient a month is because- Hospitals don’t want to do trials anymore.. 
 
Never mind that they HANDPICKED the hospital sites.
 
Never mind that hundreds of other trials are enrolling as usual.
 
Execs repeating this excuse should be ashamed. 
 
They may think that passing the blame like this absolves them of their failures.. but it comes off as a clear admission of defeat. An declaration that they do not know how to work with hospitals and get the trial done.
 
How can the BOD hear these lames excuses and just sit on their hands and not act?

P.S. are they mentioning this to potential new investors? or just to long suffering shareholders.
Comment by oilandgasman on Feb 27, 2023 10:33am
I was told something like this in an email recently from a company insider. Seems Spectral is never to blame for another fail.
Comment by hmmmmmmmm on Mar 02, 2023 2:53pm
And now we also have MM blaming ICU workers for management's inability to enroll the trial. To think Dr. Walker and Debra Foster enrolled 446 patients into the Euphrates trial. Seto and Kellum are at just 52 after 3 years. But their approach can't be the problem. No, they'll continue to shirk responsability. They'll continue to pull paychecks and award themselves millions of ...more  
Comment by BayStreetWild on Mar 02, 2023 3:36pm
It's hard to do that when you don't show up to the office. Remotely working from your house in your underwear isn't cutting it. 
Comment by Geery on Mar 02, 2023 4:43pm
My comment from the other day is seeing its way through. I mentioned the ICU comment will be brought up for the next three days by Hmmmm... He can't come back at MM with any facts/data so he keeps working the woke angle and trying to make MMs comment something bigger than it is. Pretty sure most on this board understood what he meant by it.   Nobody on this board has been pumping ...more  
Comment by BayStreetWild on Mar 02, 2023 7:48pm
What facts do you need? 50 million dollars, 3-4 years, and 52 patients to show for it.  800k a year in total ceo compensation. He's getting paid like he's running a major corporation and has the financial results of a local lemonade stand.  You can go on glassdoor.com and look at what every person working for the company has said. (It's not pretty) They ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities